QUEBEC CITY, Sept. 25 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, today announced that its President and CEO, Jurgen Engel, PhD, will
present a company overview at BioContact Quebec on Thursday, October 2, 2008,
at 2:00 pm (eastern time) in the Salle Frontenac of the Fairmont Le Château
Frontenac hotel in Quebec City, Canada.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.
For further information:
For further information: Investor Relations: Ginette Vallières, Investor
Relations Coordinator, (418) 652-8525 ext. 265, firstname.lastname@example.org; Media
Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext.